NCT05774158

Investigation of Adults With Congenital Heart Disease in the Scope of the ICF

Status unknown Last updated 17 March 2023

What this trial tests

trial testing Physiotherapy assessment in Congenital Heart Disease in 30 participants. Status unknown.

Timeline

1 December 2022

Primary endpoint
1 August 2023

1 December 2023

Quick facts

Lead sponsor	Hacettepe University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 December 2022
Primary completion	1 August 2023
Estimated completion	1 December 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• Physiotherapy assessment

Conditions studied

• Congenital Heart Disease — all drugs for Congenital Heart Disease →
• ICF — all drugs for ICF →
• Quality of Life — all drugs for Quality of Life →

Sponsor

Hacettepe University

Who can join

Adults 18 to 65, any sex, with Congenital Heart Disease or ICF. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Congenital heart disease (CHD) is one of the common birth defects with a prevalence of approximately 1 in 1000 live births worldwide. While 15% of patients with CHD reached adulthood in the past, this rate is close to 90% today thanks to advancing medicine and technology.As individuals with CHD age, they may be affected by acquired cardiovascular risk factors common in the general population in addition to heart diseases such as arterial hypertension, obesity, and diabetes, increasing the risk of metabolic disease, stroke, and coronary artery disease. In addition to these risk factors, the disease affects both the social and familial environment of the patients. In addition to the mortality and morbidity of patients, which was the most important outcome measure in the past, quality of life has become the subject of current research. The International Classification of Functioning and Health (ICF) was adopted in 2001 for the use of a common, standard language and framework for describing health and health-related conditions, and is an international and standardized classification system that can evaluate functioning, disability and health holistically. There are no studies in the literature evaluating body structure, function and activity and participation in adults with congenital heart disease within the scope of ICF. Therefore, the aim of this study is; It is the evaluation of adults with CHD according to ICF sub-parameters (body structure and functions, activity and participation, and environmental factors) and the correlation of ICF parameters with other evaluation methods.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Investigation of Community Integration in Adults with Congenital Heart Disease Within the Scope of International Classification of Functioning, Disability, and Health.
   Siyah T, Topcuoglu C, Vardar Yagli N, Calik Kutukcu E, et al · · 2026 · PMID 40188280 · DOI 10.1007/s00246-025-03850-4